kyvero
Market leaders

HQY

HealthEquity, Inc. (HQY)

Healthcare • Health Information Services

StockNasdaqGSUnited StatesUS42226A1079

102.87 USD -0.17% today Updated 13 Nov 2026 16:47

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by HealthEquity, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 16:47. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 01 Dec 2026 in 18 days · 16:00 · estimate 1.15
Last results 1.24 vs 1.19 estimated 27 Aug 2026 · Beat +3.9%
Beat the estimate 11 of 12 1 missed · 0 in line · 6 beats in a row
Average surprise +12.0% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

05 Dec 2023: estimate 0.50 05 Dec 2023: reported 0.60 12/23 19 Mar 2024: estimate 0.60 19 Mar 2024: reported 0.63 03/24 03 Jun 2024: estimate 0.65 03 Jun 2024: reported 0.80 06/24 03 Sep 2024: estimate 0.70 03 Sep 2024: reported 0.86 09/24 09 Dec 2024: estimate 0.72 09 Dec 2024: reported 0.78 12/24 18 Mar 2025: estimate 0.72 18 Mar 2025: reported 0.69 03/25 03 Jun 2025: estimate 0.81 03 Jun 2025: reported 0.97 06/25 02 Sep 2025: estimate 0.92 02 Sep 2025: reported 1.08 09/25 03 Dec 2025: estimate 0.91 03 Dec 2025: reported 1.01 12/25 17 Mar 2026: estimate 0.90 17 Mar 2026: reported 0.95 03/26 28 May 2026: estimate 1.12 28 May 2026: reported 1.24 05/26 27 Aug 2026: estimate 1.19 27 Aug 2026: reported 1.24 08/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
01 Dec 2026 16:00 1.15 — — Upcoming
27 Aug 2026 08:00 1.19 1.24 +3.9% Beat
28 May 2026 16:00 1.12 1.24 +11.2% Beat
17 Mar 2026 16:00 0.90 0.95 +5.8% Beat
03 Dec 2025 16:00 0.91 1.01 +10.7% Beat
02 Sep 2025 16:00 0.92 1.08 +17.7% Beat
03 Jun 2025 16:00 0.81 0.97 +19.3% Beat
18 Mar 2025 16:00 0.72 0.69 -3.7% Miss
09 Dec 2024 16:00 0.72 0.78 +8.0% Beat
03 Sep 2024 16:00 0.70 0.86 +23.0% Beat
03 Jun 2024 16:00 0.65 0.80 +22.2% Beat
19 Mar 2024 16:00 0.60 0.63 +5.8% Beat
05 Dec 2023 16:00 0.50 0.60 +20.0% Beat
05 Sep 2023 16:00 0.48 0.53 +11.1% Beat
05 Jun 2023 16:00 0.41 0.50 +23.4% Beat
21 Mar 2023 16:00 0.35 0.37 +5.9% Beat
06 Dec 2022 16:00 0.35 0.38 +9.7% Beat
06 Sep 2022 16:00 0.33 0.33 -0.1% In line
06 Jun 2022 16:00 0.26 0.27 +3.9% Beat
22 Mar 2022 16:00 0.21 0.20 -6.8% Miss
06 Dec 2021 16:00 0.35 0.35 +1.0% In line
08 Sep 2021 16:00 0.36 0.40 +11.2% Beat
07 Jun 2021 16:00 0.32 0.38 +19.2% Beat
15 Mar 2021 16:00 0.40 0.42 +5.2% Beat
07 Dec 2020 16:00 0.36 0.41 +14.4% Beat
08 Sep 2020 16:00 0.28 0.42 +52.5% Beat
02 Jun 2020 16:00 0.44 0.43 -1.4% Miss
16 Mar 2020 16:00 0.36 0.39 +7.1% Beat
03 Dec 2019 16:00 0.23 0.47 +107.7% Beat
03 Sep 2019 16:00 0.35 0.45 +28.0% Beat
04 Jun 2019 16:00 0.34 0.41 +20.7% Beat
18 Mar 2019 16:00 0.22 0.27 +22.0% Beat
04 Dec 2018 16:00 0.25 0.28 +10.3% Beat
04 Sep 2018 16:00 0.28 0.34 +21.7% Beat
04 Jun 2018 16:00 0.28 0.31 +10.6% Beat
19 Mar 2018 16:00 0.09 0.11 +25.9% Beat
05 Dec 2017 16:00 0.16 0.17 +7.0% Beat
05 Sep 2017 16:00 0.18 0.21 +15.9% Beat
06 Jun 2017 16:00 0.19 0.19 +1.6% Beat
21 Mar 2017 16:00 0.07 0.09 +28.3% Beat
06 Dec 2016 16:00 0.12 0.12 +6.8% Beat
06 Sep 2016 16:00 0.13 0.16 +20.4% Beat
07 Jun 2016 16:00 0.13 0.15 +17.7% Beat
22 Mar 2016 16:00 0.04 0.07 +63.3% Beat
07 Dec 2015 16:00 0.07 0.07 +2.1% Beat
08 Sep 2015 16:00 0.08 0.08 +2.0% Beat
08 Jun 2015 17:00 0.08 0.09 +14.4% Beat
24 Mar 2015 16:00 0.02 0.02 -18.3% Miss
09 Dec 2014 16:00 0.04 0.05 +25.0% Beat
09 Sep 2014 16:00 0.05 0.07 +47.4% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2026 1.3B +9.5% 215.2M 16.4% 2.46 +125.7% 408.3M
2025 1.2B +20.0% 96.7M 8.1% 1.09 +70.3% -165.6M
2024 999.6M +16.0% 55.7M 5.6% 0.64 +306.5% 196.8M
2023 861.7M — -26.1M -3.0% -0.31 — 31.5M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by month
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
Nov 2026 In progress 102.85 110.26 100.54 102.87 +0.39% 8,289,966
Oct 2026 88.46 105.55 87.79 102.47 +15.84% 16,723,500
Sep 2026 96.65 99.78 86.01 88.46 -8.37% 18,665,300
Aug 2026 101.50 107.62 88.68 96.54 -4.05% 18,205,800
Jul 2026 91.32 105.10 90.30 100.61 +11.39% 17,073,200
Jun 2026 89.53 92.35 83.10 90.32 +2.65% 21,879,300
May 2026 82.83 95.00 79.69 87.99 +7.27% 19,724,900
Apr 2026 84.02 87.97 76.03 82.03 -1.84% 20,664,500
Mar 2026 75.38 84.36 75.00 83.57 +9.26% 21,638,500
Feb 2026 85.28 88.80 72.76 76.49 -10.72% 18,906,200
51 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
103.05 USD
Market cap
8.5B
Exchange
NasdaqGS
Country
United States
Sector
Healthcare
Industry
Health Information Services
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 25.0 / 25
  • Revenue growth of 15.1% a year
Quality Return on equity, net margin and how stable the margins are. 11.9 / 25
  • ROE of 11%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 17.7 / 20
  • Net debt is 1.4× EBITDA
  • Free cash flow yield of 4.6%
Valuation Free cash flow yield and the P/E against its sector. 8.9 / 15
  • P/E 37.4 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 9.1 / 10
  • Analysts' target is +17% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 37.38× Weak 30.56×
P/E (forward) 18.76× Fair 14.16×
Price / book 4.31× Weak 3.5×
Price / sales 6.29× Weak 3.33×
EV / EBITDA 17.84× Weak 11.19×
Free cash flow yield 4.6% Fair 2.1%
Quality
FigureValueReading Sector median
Gross margin 71.2% Good 54.9%
Operating margin 28.4% Good 5.8%
Net margin 17.4% Good 1.2%
Return on equity 11.4% Fair 4.4%
Return on assets 6.7% Fair 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 15.1% Good 10.1%
Financial health
FigureValueReading Sector median
Debt / equity 0.49× Good 0.4×
Net debt / EBITDA 1.39× Good 1.46×
Interest cover 5.73× Fair 2.17×
Current ratio 2.99× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow HQY and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in